Want to see HK:2289 full AI Analyst Report?
Charmacy Pharmaceutical Co., Ltd. Class H (2289) Income Statement
Charmacy Pharmaceutical Co., Ltd. Class H Income Statement
Last quarter (Q2 2026), Charmacy Pharmaceutical Co., Ltd. Class H's total revenue was $2.45B, an increase of 4.42% from the same quarter last year. In Q2, Charmacy Pharmaceutical Co., Ltd. Class H's net income was $22.58M. See Charmacy Pharmaceutical Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 4.38B | $ 4.44B | $ 4.40B | $ 4.18B | $ 3.79B | |
| $ 336.01M | $ 324.76M | $ 292.74M | $ 268.61M | $ 234.12M | |
| $ 267.91M | $ 251.52M | $ 226.55M | $ 147.09M | $ 201.73M | |
| Depreciation and Amortization | $ 35.43M | $ 36.31M | $ 30.04M | $ 33.31M | $ 32.03M |
| $ 166.97M | $ 171.52M | $ 138.25M | $ 126.80M | $ 106.53M | |
| $ 68.10M | $ 73.25M | $ 66.19M | $ 121.52M | $ 32.39M | |
| $ -3.79M | $ -2.05M | $ 1.22M | $ 533.63K | $ 592.68K | |
| $ 64.31M | $ 71.19M | $ 67.42M | $ 122.05M | $ 32.98M | |
| $ 46.27M | $ 53.28M | $ 51.34M | $ 90.47M | $ 23.15M | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.43 | $ 0.49 | $ 0.48 | $ 0.84 | $ 0.21 |
| Diluted EPS | $ 0.43 | $ 0.49 | $ 0.48 | $ 0.84 | $ 0.21 |
| Weighted Average Shares Outstanding | 107.99M | 107.98M | 108.00M | 107.99M | 107.99M |
| Weighted Average Shares Outstanding (Diluted) | 107.99M | 107.98M | 108.00M | 107.99M | 107.99M |
Currency in CNY
